Condition: Bacterial Keratitis · Antibiotic-resistant Bacteria · Infections, Bacterial · Sponsor: Eye & ENT Hospital of Fudan University
The purpose of this study is to evaluate the safety and efficacy of GP-asPNA for in vivo treatment of severe antibiotic resistant bacterial keratitis.
This description comes directly from the study's public registry record.
Jiaxu Hong, M.D., Ph.D · +86-021-64377134 · chengmingruicmr@163.com
Always discuss trial participation with your own doctor first.
| Eye & ENT Hospital of Fudan University | Shanghai, Shanghai Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06451172